samedan logo
 
 
spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


Starting in December 2009, EPC’s board of Industry Advisers will help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.

Ashok Bhat
VP of International Services
Phase Forward

Jane Clarke
Assistant Vice President
Wyeth Research

Kevin Deane
Managing Consultant
PA Consulting Group

Beatrijs Van Liedekerke
Director, Advisory Services
PricewaterhouseCoopers

Mats Sundgren
Principal Scientist, Global Clinical Development
AstraZeneca

Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development

Andrew Kelley
Senior Vice President, Commercial Operations, Europe & Asia Pacific
Patheon

 

For further information please contact:

Advertising
Jonathan Smith
Adam Mancey

Editorial
Ekaete Inyang

View the digital version of EPC

epc
 
 
Featured in this issue
Marketplace & Business
During the past 10 years, the number of biopharmaceuticals in the market has exploded and we expect this trend to continue. Scott E Boley of MPI Research highlights the differences between biopharmaceuticals and their predecessor small molecules, with respect to nonclinical development.
SPECIAL FEATURE: ONCOLOGY
Standardised oncology assessment criteria are essential to the validity of oncology clinical trial outcome data, explain Stephen Bates and Kelie Luby at Perceptive Informatics.
  Clinical Development
The phrase 'time is money' certanily applies to pharmaceuticals; Graham Woods of Cetero Research illustrates how to safely accelerate through the drug development race track and shorten the journey from proof-of-concept to first-in-human studies.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December

 

 
Industry Events

CPhI India

1-3 December 2010, Mumbai, India

With the Indian market fast becoming a major global economy and with its pharmaceutical market expected to treble over the years to 2015, CPhI India 2009 is a unique chance to link up with the very best in this industry as they gather to discuss the key issues, trends and developments in one location. Generate new alliances, renew existing partnerships and benefit from the dynamic networking opportunities available to actively drive your business forward. Attend CPhI India 2009 – the perfect environment for growth.
More info >>

 
News and Press Releases

Glycotope GMBH

Berlin, Germany – August 4, 2010 Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >>

air transport logo

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement